Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice
- PMID: 2020004
Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice
Abstract
Azidothymidine (AZT) is the only approved drug for treatment of acquired immunodeficiency syndrome caused by human immunodeficiency virus. The drug is known to be metabolized by mammalian systems. The objectives of this study were: 1) to investigate the biologic fate of AZT using whole-body autoradiography; and 2) to compare the biologic fate of AZT with that of the parent molecule thymidine (dThd). Male Sprague-Dawley mice were given (intravenously) a tracer dose of [2-14C]AZT (273 microCi/kg) or [2-14C]dThd (218 microCi/kg). Treated animals were sacrificed at various time periods (2 min, 5 min, 4 hr and 24 hr) and processed for whole-body autoradiography. Tissue distribution of radioactivity in the autoradiographs was quantitated using computer-aided image analysis. The elimination of AZT and dThd was also examined by radiochemical analyses of urine, feces and expired air of treated animals over a 24-hr period. Twenty-four hr following AZT treatment, the radioactivity excreted in urine, feces and in exhaled air (as 14CO2) accounted for 86, 4.6 and 3.7% of the dose, respectively. Within 2 min after administration of AZT, maximum radioactivity was detected in the kidney. The brain, spinal cord and testes were conspicuous because of virtual lack of radioactivity. All other parenchymatous organs (liver, lung, heart and spleen) had apparent similar levels of radioactivity that were higher than those in the connective tissues. At a later time period (4 hr), the radioactivity in most organs was eliminated except in the renal medulla, contents of gastrointestinal tract, urinary bladder and mouth cavity.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Effects of dose, strain, and dosing vehicle on methacrylonitrile disposition in rats and identification of a novel-exhaled metabolite.Drug Metab Dispos. 1992 Sep-Oct;20(5):643-52. Drug Metab Dispos. 1992. PMID: 1358567
-
Route-dependent comparative metabolism of [14C]toluene 2,4-diisocyanate and [14C]toluene 2,4-diamine in Fischer 344 rats.Toxicol Appl Pharmacol. 1994 Feb;124(2):181-90. doi: 10.1006/taap.1994.1022. Toxicol Appl Pharmacol. 1994. PMID: 8122263
-
Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats.J Pharmacol Exp Ther. 1993 Dec;267(3):1181-90. J Pharmacol Exp Ther. 1993. PMID: 8166890
-
NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).Natl Toxicol Program Tech Rep Ser. 1996 Aug;383:1-370. Natl Toxicol Program Tech Rep Ser. 1996. PMID: 12692653
-
Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging.J Nucl Med. 2006 Oct;47(10):1717-22. J Nucl Med. 2006. PMID: 17015909
Cited by
-
Flow injection with chemical reaction interface-isotope ratio mass spectrometry: an alternative to off-line combustion for detecting low levels of enriched 13C in mass balance studies.J Am Soc Mass Spectrom. 1999 Feb;10(2):153-8. doi: 10.1016/S1044-0305(98)00133-0. J Am Soc Mass Spectrom. 1999. PMID: 9926407
-
Mrp4 confers resistance to topotecan and protects the brain from chemotherapy.Mol Cell Biol. 2004 Sep;24(17):7612-21. doi: 10.1128/MCB.24.17.7612-7621.2004. Mol Cell Biol. 2004. PMID: 15314169 Free PMC article.
-
Mitochondrial and metabolic effects of nucleoside reverse transcriptase inhibitors (NRTIs) in mice receiving one of five single- and three dual-NRTI treatments.Antimicrob Agents Chemother. 2003 Nov;47(11):3384-92. doi: 10.1128/AAC.47.11.3384-3392.2003. Antimicrob Agents Chemother. 2003. PMID: 14576092 Free PMC article.